CancerGEMKB logo   CancerGEM KB (Cancer Genomic Evidence-based Medicine Knowledge Base) (version 1.0)
   An integrated, searchable knowledge base of cancer human genome epidemiology and genomic applications in cancer care and prevention .
line
 Last data upload: 08 Aug 2014. (Total 23160 articles)  

Cancer HuGE Literature Finder

Data collected since 2001

Home  |  About  |  Search Instructions |  FAQs 

Search  
 for
Search Criteria: All publications

Filtered By  

Articles 1 - 25 of 23160
Export Display on    of 927
1.
Variants in motilin, somatostatin and their receptor genes and risk of biliary tract cancers and stones in Shanghai, China. [Detail]
Meta gene 2014 Dec 2 .
Xu HL, Hsing AW, Koshiol J, Chu LW, Cheng JR, Gao J, Tan YT, Wang BS, Shen MC, Gao YT
2.
A polymorphism in the 3' untranslated region of Hypoxia-Inducible Factor-1 alpha confers an increased risk of cervical cancer in a?Chinese population. [Detail]
Neoplasma 2014 61 (1): 1.
Fu SL, Miao J, Ding B, Wang XL, Cheng WJ, Dai HH, Han SP
3.
ATM and TGFB1 genes polymorphisms in prediction of late complications of chemoradiotherapy in patients with locally advanced cervical cancer. [Detail]
Neoplasma 2014 61 (1): 1.
Paulikova S, Petera J, Sirak I, Vosmik M, Drastikova M, Dusek L, Cvanova M, Soumarova R, Spacek J, Beranek M
4.
Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients. [Detail]
Molecular and clinical oncology 2014 Sep 2 (5): 5.
Yashima H, Shimizu K, Araki T, Aomori T, Ohtaki Y, Nagashima T, Enokida Y, Atsumi J, Nakamura T, Takeyoshi I, Yamamoto K
5.
Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: A meta-analysis. [Detail]
Biomedical reports 2014 Sep 2 (5): 5.
Yang M, Li C, Li M
6.
Clinical usefulness of testing for UDP glucuronosyltransferase 1 family, polypeptide A1 polymorphism prior to the inititation of irinotecan-based chemotherapy. [Detail]
Molecular and clinical oncology 2014 Sep 2 (5): 5.
Harada T, Saito H, Karino F, Isaka T, Murakami S, Kondo T, Oshita F, Miyagi Y, Yamada K
7.
IFRD1 polymorphisms and gastric cancer risk in a Chinese population. [Detail]
Medical oncology (Northwood, London, England) 2014 Sep 31 (9): 9.
Xu R, Peng C, Xiao S, Zhuang W
8.
Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations. [Detail]
International journal of oncology 2014 Sep 45 (3): 3.
Chevrier S, Arnould L, Ghiringhelli F, Coudert B, Fumoleau P, Boidot R
9.
Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk. [Detail]
Biomedical reports 2014 Sep 2 (5): 5.
Enokida Y, Shimizu K, Kakegawa S, Atsumi J, Takase Y, Miyamae Y, Nagashima T, Ohtaki Y, Kaira K, Sunaga N, Yanagitani N, Yoshino R, Tsunekawa K, Igai H, Kamiyoshihara M, Usui K, Lezhava A, Tomizawa Y, Ishikawa T, Murakami M, Hayashizaki Y, Takeyoshi I
10.
Surrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor gene. [Detail]
Molecular and clinical oncology 2014 Sep 2 (5): 5.
Yoshino R, Imai H, Mori K, Takei K, Tomizawa M, Kaira K, Yoshii A, Tomizawa Y, Saito R, Yamada M
11.
A functional variant at miR-132-3p, miR-212-3p, and miR-361-5p binding site in CD80 gene alters susceptibility to gastric cancer in a Chinese Han population. [Detail]
Medical oncology (Northwood, London, England) 2014 Aug 31 (8): 8.
Wu R, Li F, Zhu J, Tang R, Qi Q, Zhou X, Li R, Wang W, Hua D, Chen W
12.
A single nucleotide polymorphism in fibronectin 1 determines tumor shape in colorectal cancer. [Detail]
Oncology reports 2014 Aug 32 (2): 2.
Kida H, Takano Y, Yamamoto K, Mori M, Yanaga K, Tanaka J, Kudo SE, Mimori K
13.
Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status. [Detail]
PloS one 2014 9 (8): 8.
Lee J, Jain A, Kim P, Lee T, Kuller A, Princen F, Kim SH, Park JO, Park YS, Singh S, Kim HC
14.
Association between genetic variant in hsa-miR-146a gene and prostate cancer progression: evidence from Serbian population. [Detail]
Cancer causes & control : CCC 2014 Aug .
Nikoli? ZZ, Savi? Pavi?evi? DL, Vukoti? VD, Tomovi? SM, Cerovi? SJ, Filipovi? N, Romac SP, Braju?kovi? GN
15.
Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population. [Detail]
Medical oncology (Northwood, London, England) 2014 Aug 31 (8): 8.
Hashemi M, Amininia S, Ebrahimi M, Hashemi SM, Yousefi J, Eskandari-Nasab E, Taheri M, Ghavami S
16.
Association of Cyclin D1 Variants with Head and Neck Cancer Susceptibility: Evidence from a Meta-analysis. [Detail]
Asian Pacific journal of cancer prevention : APJCP 2014 15 (14): 14.
Lin H, Fang L, Lin D
17.
Association of dietary intake of folate and MTHFR genotype with breast cancer risk. [Detail]
Genetics and molecular research : GMR 2014 13 (3): 3.
Wang ZG, Cui W, Yang LF, Zhu YQ, Wei WH
18.
Association of glutathione S-transferase P1 gene polymorphism with the risk of small-cell carcinoma of lung cancer. [Detail]
Journal of receptor and signal transduction research 2014 Aug .
Ou C, Zhu B, Zhao HL, Huang LS, Li PZ, Lao M, Li LQ
19.
Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study. [Detail]
Cancer causes & control : CCC 2014 Aug .
Boone SD, Baumgartner KB, Baumgartner RN, Connor AE, Pinkston CM, Rai SN, Riley EC, Hines LM, Giuliano AR, John EM, Stern MC, Torres-Mejía G, Wolff RK, Slattery ML
20.
Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma: Invasive Mucinous Pattern and Extracellular Mucin Are Associated With KRAS Mutation. [Detail]
The American journal of surgical pathology 2014 Aug 38 (8): 8.
Kadota K, Yeh YC, D'Angelo SP, Moreira AL, Kuk D, Sima CS, Riely GJ, Arcila ME, Kris MG, Rusch VW, Adusumilli PS, Travis WD
21.
Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: A case control study. [Detail]
Clinics and research in hepatology and gastroenterology 2014 Aug .
Li Z, Ding Y, Zhu Y, Yin M, Le X, Wang L, Yang Y, Zhang Q
22.
BRAFV600E Mutation Associated With Non-Radioiodine-Avid Status in Distant Metastatic Papillary Thyroid Carcinoma. [Detail]
Clinical nuclear medicine 2014 Aug 39 (8): 8.
Yang K, Wang H, Liang Z, Liang J, Li F, Lin Y
23.
Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial. [Detail]
Annals of hematology 2014 Aug 93 (8): 8.
Aslanyan MG, Kroeze LI, Langemeijer SM, Koorenhof-Scheele TN, Massop M, van Hoogen P, Stevens-Linders E, van de Locht LT, Tönnissen E, van der Heijden A, da Silva-Coelho P, Cilloni D, Saglio G, Marie JP, Tang R, Labar B, Amadori S, Muus P, Willemze R, Marijt EW, de Witte T, van der Reijden BA, Suciu S, Jansen JH
24.
Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population. [Detail]
Medical oncology (Northwood, London, England) 2014 Aug 31 (8): 8.
Choudhury JH, Choudhury B, Kundu S, Ghosh SK
25.
Comparison of K-ras mutations in lung, colorectal and gastric cancer. [Detail]
Oncology letters 2014 Aug 8 (2): 2.
Peng N, Zhao X
Export Display 25 on page   1 of  927
Articles 1 - 25 of 23160